EBIT: Income before interest and taxes.
Cue Biopharma, Inc. (CUE) had EBIT of $-8.63M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$2.95M |
|
$-8.48M |
|
-- |
|
$2.95M |
|
$11.59M |
|
$-8.63M |
|
$0.15M |
|
$-8.48M |
|
$-8.48M |
|
$-8.48M |
|
$-8.48M |
|
$-8.48M |
|
$-8.48M |
|
|
EBIT |
$-8.63M |
$-8.53M |
|
95.46M |
|
95.46M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$30.84M |
|
$0.45M |
|
$9.86M |
|
$40.71M |
|
$19.25M |
|
$0.19M |
|
$3.29M |
|
$22.55M |
|
$18.16M |
|
$18.16M |
|
$18.16M |
|
76.45M |
|
| Cash Flow Statement Financials | |
$-11.59M |
|
$-0.18M |
|
$16.80M |
|
$22.61M |
|
$27.64M |
|
$5.03M |
|
$2.60M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.60 |
|
-- |
|
-- |
|
0.01 |
|
0.14 |
|
100.00% |
|
-292.32% |
|
-292.32% |
|
-- |
|
-287.14% |
|
-287.14% |
|
$-11.76M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
5.55 |
|
16.21 |
|
-46.71% |
|
-46.71% |
|
-20.84% |
|
-46.23% |
|
$0.24 |
|
$-0.12 |
|
$-0.12 |
|